Verition Fund Management LLC Edwards Lifesciences Corp Put Options Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $1.29 Million - $1.44 Million	15,300 Added 347.73%	19,700 $1.82 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $319,176 - $420,464	4,400 New	4,400 $420,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $792,280 - $1.01 Million	-11,600 Reduced 77.85%	3,300 $246,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.23 Million - $1.6 Million	14,900 New	14,900 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $1.38 Million - $2.05 Million	-16,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $112,156 - $141,174	1,100 Added 7.38%	16,000 $1.88 Million
Q4 2021 May 03, 2022	BUY	$106.37 - $130.68 $1.58 Million - $1.95 Million	14,900 New	14,900 $1.93 Million

1,350

462M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $42.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.